‘Strong immune response’ mixing AstraZeneca and Pfizer COVID-19 jabs

Covid vaccine

Research published in The Lancet suggests mixed vaccine schedules induce high concentrations of antibodies against SARS-CoV-2

Please register to continue reading this content

Guidelines is completely free for all UK-based healthcare professionals